• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌检测不当、随之而来的过度治疗以及公开报告的指标不准确。

Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.

作者信息

Kelly Sean G, Yarrington Michael, Zembower Teresa R, Sutton Sarah H, Silkaitis Christina, Postelnick Michael, Mikolajczak Anessa, Bolon Maureen K

机构信息

1Vanderbilt University School of Medicine,Division of Infectious Diseases,Nashville,Tennessee.

2Northwestern Feinberg School of Medicine,Department of Medicine,Chicago,Illinois.

出版信息

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1395-1400. doi: 10.1017/ice.2016.210. Epub 2016 Sep 26.

DOI:10.1017/ice.2016.210
PMID:27666285
Abstract

BACKGROUND The nationally reported metric for Clostridium difficile infection (CDI) relies solely on laboratory testing, which can result in overreporting due to asymptomatic C. difficile colonization. OBJECTIVE To review the clinical scenarios of cases of healthcare facility-onset CDI (HO-CDI) and to determine the appropriateness of C. difficile testing on the basis of presence of symptomatic diarrhea in order to identify areas for improvement. DESIGN Retrospective cohort study. SETTING Northwestern Memorial Hospital, a large, tertiary academic hospital in Chicago, Illinois. PATIENTS The cohort included all patients with a positive C. difficile test result who were reported to the National Healthcare Safety Network as HO-CDI during a 1-year study period. METHODS We reviewed the clinical scenario of each HO-CDI case. On the basis of documentation and predefined criteria, appropriateness of C. difficile testing was determined; cases were deemed appropriate, inappropriate, or indeterminate. Statistical analysis was performed to compare demographic and clinical parameters among the categories of testing appropriateness. RESULTS Our facility reported 168 HO-CDI cases to NHSN during the study period. Of 168 cases, 33 (19.6%) were judged to be appropriate tests, 25 (14.8%) were considered inappropriate, and 110 (65.5%) were indeterminate. Elimination of inappropriate testing would have improved our facility's standardized infection ratio from 0.962 to 0.819. CONCLUSION Approximately 15% of HO-CDI cases were judged to be tested inappropriately. Testing only patients with clinically significant diarrhea would more accurately estimate CDI incidence, reduce unnecessary antibiotic use, and improve facilities' performance of reportable CDI metrics. Improved documentation could facilitate targeted interventions. Infect Control Hosp Epidemiol 2016;1395-1400.

摘要

背景

全国报告的艰难梭菌感染(CDI)指标仅依赖实验室检测,这可能因无症状艰难梭菌定植导致报告过度。目的:回顾医疗机构获得性CDI(HO-CDI)病例的临床情况,并根据是否存在症状性腹泻来确定艰难梭菌检测的适宜性,以找出可改进之处。设计:回顾性队列研究。地点:伊利诺伊州芝加哥的大型三级学术医院西北纪念医院。患者:该队列包括在为期1年的研究期间被报告给国家医疗安全网络的所有艰难梭菌检测结果呈阳性的HO-CDI患者。方法:我们回顾了每例HO-CDI病例的临床情况。根据记录和预定义标准确定艰难梭菌检测的适宜性;病例被判定为适宜、不适宜或不确定。进行统计分析以比较检测适宜性类别之间的人口统计学和临床参数。结果:在研究期间,我们的机构向国家医疗安全网络报告了168例HO-CDI病例。在这168例病例中,33例(19.6%)被判定为检测适宜,25例(14.8%)被认为不适宜,110例(65.5%)不确定。消除不适当检测将使我们机构的标准化感染率从0.962提高到0.819。结论:约15%的HO-CDI病例被判定检测不当。仅对有临床显著腹泻的患者进行检测将更准确地估计CDI发病率,减少不必要的抗生素使用,并改善机构在可报告CDI指标方面的表现。改进记录有助于进行有针对性的干预。《感染控制与医院流行病学》2016年;1395 - 1400。

相似文献

1
Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.艰难梭菌检测不当、随之而来的过度治疗以及公开报告的指标不准确。
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1395-1400. doi: 10.1017/ice.2016.210. Epub 2016 Sep 26.
2
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.腹泻发作和泻药治疗的实时电子追踪可验证艰难梭菌临床检测标准并降低艰难梭菌感染率。
J Clin Microbiol. 2017 May;55(5):1276-1284. doi: 10.1128/JCM.02319-16. Epub 2017 Mar 1.
3
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.分子检测时代艰难梭菌感染的过度诊断
JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.
4
Nosocomial-acquired and community-onset Clostridium difficile infection at an academic hospital in Italy: Epidemiology, recurrences and toxin genes distribution.意大利一家学术医院的医院获得性和社区起病艰难梭菌感染:流行病学、复发情况及毒素基因分布
J Infect Chemother. 2017 Nov;23(11):763-768. doi: 10.1016/j.jiac.2017.08.002. Epub 2017 Sep 9.
5
C. difficile infection (CDI) in a long-term acute care facility (LTAC).长期急性护理机构(LTAC)中的艰难梭菌感染(CDI)。
Anaerobe. 2009 Dec;15(6):241-3. doi: 10.1016/j.anaerobe.2009.06.009. Epub 2009 Aug 13.
6
Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score.住院入院时预测医院获得性艰难梭菌感染(HO-CDI)的风险:HO-CDI风险评分
Infect Control Hosp Epidemiol. 2015 Jun;36(6):695-701. doi: 10.1017/ice.2015.37. Epub 2015 Mar 10.
7
Overreporting healthcare-associated C. difficile: A comparison of NHSN LabID with clinical surveillance definitions in the era of molecular testing.过度报告医疗保健相关的艰难梭菌:在分子检测时代 NHSN LabID 与临床监测定义的比较。
Am J Infect Control. 2018 Sep;46(9):998-1002. doi: 10.1016/j.ajic.2018.03.001. Epub 2018 Apr 11.
8
Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions.儿童社区相关性艰难梭菌感染病例的临床和微生物学评估揭示了改进检测决策的机会。
Pediatr Infect Dis J. 2016 Feb;35(2):157-61. doi: 10.1097/INF.0000000000000954.
9
Current knowledge on the laboratory diagnosis of infection.关于感染实验室诊断的当前知识。
World J Gastroenterol. 2017 Mar 7;23(9):1552-1567. doi: 10.3748/wjg.v23.i9.1552.
10
The impact of an electronic medical record nudge on reducing testing for hospital-onset infection.电子病历提示对降低医院获得性感染检测的影响。
Infect Control Hosp Epidemiol. 2020 Apr;41(4):411-417. doi: 10.1017/ice.2020.12. Epub 2020 Feb 10.

引用本文的文献

1
Validation of electronic health record data to identify hospital-associated infections for retrospective research.验证电子健康记录数据以识别用于回顾性研究的医院相关感染。
Infect Control Hosp Epidemiol. 2024 Oct 16;45(12):1-3. doi: 10.1017/ice.2024.140.
2
Prevalence of Non-Toxigenic in Diarrhoea Patients and Their Clinical Characteristics.腹泻患者中非产毒型的患病率及其临床特征。
Antibiotics (Basel). 2023 Aug 24;12(9):1360. doi: 10.3390/antibiotics12091360.
3
Leveraging diagnostic stewardship within antimicrobial stewardship programmes.
在抗菌药物管理计划中利用诊断管理
Drugs Context. 2023 Feb 20;12. doi: 10.7573/dic.2022-9-5. eCollection 2023.
4
The value of fecal calprotectin in infection: A systematic review.粪便钙卫蛋白在感染中的价值:一项系统综述。
Front Physiol. 2022 Aug 3;13:881816. doi: 10.3389/fphys.2022.881816. eCollection 2022.
5
Prevalence of and factors associated with inappropriate Clostridioides difficile testing in a teaching hospital in Korea.韩国一家教学医院中与不适当艰难梭菌检测相关的流行率及相关因素。
Antimicrob Resist Infect Control. 2022 May 13;11(1):70. doi: 10.1186/s13756-022-01111-0.
6
Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects.黑色素瘤筛查、诊断和预后的分子生物标志物:现状与未来展望
Front Med (Lausanne). 2021 Apr 16;8:642380. doi: 10.3389/fmed.2021.642380. eCollection 2021.
7
Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.分析社区获得性肺炎住院患者中艰难梭菌感染的危险因素。
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0041721. doi: 10.1128/AAC.00417-21.
8
Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis.艰难梭菌:诊断与过度诊断的后果
Infect Dis Ther. 2021 Jun;10(2):687-697. doi: 10.1007/s40121-021-00417-7. Epub 2021 Mar 26.
9
The Role of Diagnostic Stewardship in Testing: Challenges and Opportunities.诊断管理在检测中的作用:挑战与机遇
Curr Infect Dis Rep. 2020 Mar;22(3). doi: 10.1007/s11908-020-0715-4. Epub 2020 Feb 17.
10
Direct Measurement of Performance: A New Era in Antimicrobial Stewardship.性能的直接测量:抗菌药物管理的新时代。
Antibiotics (Basel). 2019 Aug 24;8(3):127. doi: 10.3390/antibiotics8030127.